An ASH Review and Q&A with Dr. Sborov image

An ASH Review and Q&A with Dr. Sborov

Jan 19, 2022
01:00PM - 02:00PM MST
Online Event
Overview

Dr. Sborov will explain some of his highlights from the myeloma presentations at last month’s American Society of Hematology (ASH) conference. This will be followed by an open-ended question-and-answer session.  Please note this session is only for myeloma patients and caregivers. 

Dr. Sborov also plans to ask for feedback about how well Huntsman’s Multiple Myeloma Program served patients and caregivers in 2021, and about opportunities to improve the program in 2022. This portion of the meeting will also be open-ended, and some questions related to COVID-19 will likely be addressed, too. Hope you can join us!

Agenda
01:00 PM
Introduction
Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speakers Nico Cheek-O'Donnell and Dr. Douglas Sborov.  
01:05 PM
Presentation
Nico Cheek-O'Donnell and Dr. Douglas Sborov
Dr. Sborov discusses some of the interesting and exciting things from the 2021 session of ASH (the global American Society of Hematology Conference).
01:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them! 
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Douglas Sborov, MD

Douglas Sborov, MD

Dr. Douglas Sborov is an Assistant Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. He was born and raised in Minnesota, completed his undergraduate education with a Bachelor of Science at the University of Wisconsin-Madison, later completed medical school through the American University of the Caribbean, and spent 3 years in Salt Lake City for his internal medicine residency. After almost 5 years in Columbus, OH, completing hematology, oncology, and bone marrow transplantation fellowships and joining the Division of Hematology as a Clinical Instructor, he and his family were drawn back to the beauty of the Wasatch Front where he joined the Division of Hematology to continue his career as a clinical trialist focused on the treatment of patients with hematologic malignancies. Dr. Sborov is the Director of the Multiple Myeloma Program, an Associate Member of the Huntsman Cancer Institute Experimental Therapeutics Program, Physician Leader of the Multiple Myeloma/Bone Marrow Transplant arm of the HCI Clinical Trials Office (CTO), and an active member of the HCI Protocol Review and Monitoring Committee.
Healthtree contact Nico Cheek-O'Donnell

Nico Cheek-O'Donnell

Nico joined the Multiple Myeloma Program at Huntsman Cancer Institute in 2016, as its licensed clinical social worker. Before that, he was a social worker with Intermountain, primarily at LDS Hospital on their inpatient behavioral unit. He earned his Master of Social Work degree at the University of Utah. Originally from New York & Boston, Nico earned undergraduate degrees in Psychology & Theatre from Carleton College in Minnesota. He earned most of his very modest living as a stage actor in Minneapolis and Seattle for eight years, before moving to Utah in 2006. More recently, Nico has used role-play to help train physicians how to navigate especially difficult patient conversations – and to entertain his 13 & 9-year-old kids.